Sort
48,018 grants matching “immunotherapy”
Studying the initiation, progression and therapy of lung cancer in mouse models
$365,750Martin McMahon · University Of Utah · R01 · FY2024 · CA
MATCHMAKERS
$365,699David Baker · University Of Washington · OT2 · FY2025 · CA
Dendritic Cell-NK T Cell Interactions in the SLE
$365,695Stanford University · R01 · FY2004 · AR
Project 3: Myeloid-lymphoid cell crosstalk in HNSCC therapy
$365,650Mikael Pittet · Yale University · P01 · FY2023 · CA
Preclinical Study of Peptide Based Human Tumor Vaccines
$365,628University Of Virginia Charlottesville · R01 · FY2003 · CA
Fibroblast Activation Protein as a Potential Diagnostic and Therapeutic Target to Treat Chronic Allograft Dysfunction
$365,625Vijay Bhoj · University Of Pennsylvania · R56 · FY2024 · AI
Sublingual Immunotherapy for Peanut Allergy
$365,621Arvil Wesley Burks · Univ Of North Carolina Chapel Hill · R01 · FY2012 · AT
The adaptor protein Crk in immune responses
$365,605Dongfang Liu · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
MYC activation in tumor progression of neuroblastoma
$365,574Min Hee Kang · Texas Tech University Health Scis Center · R01 · FY2023 · CA
MYC activation in tumor progression of neuroblastoma
$365,572Min Hee Kang · Texas Tech University Health Scis Center · R01 · FY2022 · CA
Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies
$365,534William Joseph Murphy · University Of California At Davis · R01 · FY2016 · CA
Imaging of macrophage trafficking with ultrasound
$365,523Konstantinos-Costas Arvanitis · Georgia Institute Of Technology · R21 · FY2024 · EB
Immunopathogenesis of Coxiella pneumonia
$365,520Allen G Harmsen · Colorado State University · U54 · FY2007 · AI
Engineering Protein Modulators of Notch Activation for T-cell immunotherapy
$365,513Joseph M. Muretta · University Of Minnesota · R33 · FY2024 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$365,513Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Project 3: Modulation of the head and neck tumor immune microenvironment by targeting the TAM family of receptors
$365,499Deric L Wheeler · University Of Wisconsin-Madison · P50 · FY2023 · CA
Targeting the colchicine site in tubulin for advanced melanoma
$365,493Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2017 · CA
Targeting the colchicine site in tubulin for advanced melanoma
$365,493Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2018 · CA
Targeting the colchicine site in tubulin for advanced melanoma
$365,493Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2020 · CA
Project 3: Development of Novel Therapies and Biomarkers for TNBC Patients
$365,447Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
Determinants of prostate cancer sensitivity to PD-1 blockade
$365,428Lawrence Fong · University Of California, San Francisco · R01 · FY2018 · CA
Project 4: Activity of CAR T cell Therapy for Patients with Metastatic TNBC
$365,428Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
PEDIATRIC ONCOLOGY GROUP
$365,389Baylor College Of Medicine · U10 · FY2001 · CA
TCR engineering of human T cells for immunotherapy of hepatocellular carcinoma
$365,377Yukai He · Augusta University · R01 · FY2022 · CA
TCR engineering of human T cells for immunotherapy of hepatocellular carcinoma
$365,377Yukai He · Augusta University · R01 · FY2023 · CA